High GMFG expression correlates with poor prognosis and promotes cell migration and invasion in epithelial ovarian cancer

Gynecologic Oncology

Volumn 132, Issue 3, 2014, Pages 745-751

  Zuo, Peng ^a   Ma, Yuejiang ^a   Huang, Yongjie ^a   Ye, Feng ^a   Wang, Pei ^a   Wang, Xinyu ^a   Zhou, Caiyun ^a   Lu, Weiguo ^a   Kong, Beihua ^b   Xie, Xing ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Actin cytoskeleton; Cell migration; GMFG; Ovarian cancer; Prognosis

Indexed keywords

ACTIN RELATED PROTEIN 2-3 COMPLEX; GLIA MATURATION FACTOR; GLIA MATURATION FACTOR GAMMA; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ADENOMA; ARTICLE; CANCER CELL CULTURE; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CLEAR CELL CARCINOMA; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VITRO STUDY; OVARY CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; WOUND HEALING;

ACTIN CYTOSKELETON; CELL MIGRATION; GMFG; OVARIAN CANCER; PROGNOSIS;

ACTINS; CELL LINE, TUMOR; CELL MOVEMENT; CYTOSKELETON; DISEASE-FREE SURVIVAL; FEMALE; FORMALDEHYDE; GLIA MATURATION FACTOR; HUMANS; KAPLAN-MEIER ESTIMATE; NEOPLASM INVASIVENESS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PARAFFIN EMBEDDING; PROGNOSIS; TISSUE FIXATION; TRANSFECTION;

EID: 84896395500     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.01.044     Document Type: Article

References (29)

1. M. Kyrgiou, G. Salanti, N. Pavlidis, E. Paraskevaidis, and J.P. Ioannidis Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments J Natl Cancer Inst 98 2006 1655 1663
2. R.J. Bast, B. Hennessy, and G.B. Mills The biology of ovarian cancer: new opportunities for translation Nat Rev Cancer 9 2009 415 428
3. M. Gandhi, B.A. Smith, M. Bovellan, V. Paavilainen, K. Daugherty-Clarke, and J. Gelles et al. GMF is a cofilin homolog that binds Arp2/3 complex to stimulate filament debranching and inhibit actin nucleation Curr Biol 20 2010 861 867
4. K. Nakano, H. Kuwayama, M. Kawasaki, O. Numata, and M. Takaine GMF is an evolutionarily developed Adf/cofilin-super family protein involved in the Arp2/3 complex-mediated organization of the actin cytoskeleton Cytoskeleton (Hoboken) 67 2010 373 382
5. P. Zuo, Z. Fu, T. Tao, F. Ye, L. Chen, and X. Wang et al. The expression of glia maturation factors and the effect of glia maturation factor-gamma on angiogenic sprouting in zebrafish Exp Cell Res 319 2013 707 717
6. A. Zaheer, and R. Lim Overexpression of glia maturation factor (GMF) in PC12 pheochromocytoma cells activates p38 MAP kinase, MAPKAP kinase-2, and tyrosine hydroxylase Biochem Biophys Res Commun 250 1998 278 282
7. R. Lim, and A. Zaheer In vitro enhancement of p38 mitogen-activated protein kinase activity by phosphorylated glia maturation factor J Biol Chem 271 1996 22953 22956
8. R. Lim, A. Zaheer, M.A. Yorek, C.J. Darby, and L.W. Oberley Activation of nuclear factor-kappaB in C6 rat glioma cells after transfection with glia maturation factor J Neurochem 74 2000 596 602
9. Y.L. Li, F. Ye, X.D. Cheng, Y. Hu, C.Y. Zhou, and W.G. Lu et al. Identification of glia maturation factor beta as an independent prognostic predictor for serous ovarian cancer Eur J Cancer 46 2010 2104 2118
10. K. Ikeda, R.K. Kundu, S. Ikeda, M. Kobara, H. Matsubara, and T. Quertermous Glia maturation factor-gamma is preferentially expressed in microvascular endothelial and inflammatory cells and modulates actin cytoskeleton reorganization Circ Res 99 2006 424 433
11. D.N. Lippert, and J.A. Wilkins Glia maturation factor gamma regulates the migration and adherence of human T lymphocytes BMC Immunol 13 2012 21
12. W. Aerbajinai, L. Liu, K. Chin, J. Zhu, C.A. Parent, and G.P. Rodgers Glia maturation factor-gamma mediates neutrophil chemotaxis J Leukoc Biol 90 2011 529 538
13. E.H. Mahlamaki, P. Kauraniemi, O. Monni, M. Wolf, S. Hautaniemi, and A. Kallioniemi High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer Neoplasia 6 2004 432 439
14. R. Kuuselo, K. Savinainen, D.O. Azorsa, G.D. Basu, R. Karhu, and S. Tuzmen et al. Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification Cancer Res 67 2007 1943 1949
15. T.C. Tang, J.S. Sham, D. Xie, Y. Fang, K.K. Huo, and Q.L. Wu et al. Identification of a candidate oncogene SEI-1 within a minimal amplified region at 19q13.1 in ovarian cancer cell lines Cancer Res 62 2002 7157 7161
16. H. van Dekken, J.C. Alers, P.H. Riegman, C. Rosenberg, H.W. Tilanus, and K. Vissers Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions Am J Pathol 158 2001 1961 1967
17. X.P. Hao, T.G. Pretlow, J.S. Rao, and T.P. Pretlow Beta-catenin expression is altered in human colonic aberrant crypt foci Cancer Res 61 2001 8085 8088
18. L. Zhang, F. Ding, W. Cao, Z. Liu, W. Liu, and Z. Yu et al. Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma Clin Cancer Res 12 2006 1639 1646
19. D.J. Slamon, W. Godolphin, L.A. Jones, J.A. Holt, S.G. Wong, and D.E. Keith et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer Science 244 1989 707 712
20. S.L. Anzick, J. Kononen, R.L. Walker, D.O. Azorsa, M.M. Tanner, and X.Y. Guan et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer Science 277 1997 965 968
21. J.S. Sham, T.C. Tang, Y. Fang, L. Sun, L.X. Qin, and Q.L. Wu et al. Recurrent chromosome alterations in primary ovarian carcinoma in Chinese women Cancer Genet Cytogenet 133 2002 39 44
22. H. Iwabuchi, M. Sakamoto, H. Sakunaga, Y.Y. Ma, M.L. Carcangiu, and D. Pinkel et al. Genetic analysis of benign, low-grade, and high-grade ovarian tumors Cancer Res 55 1995 6172 6180
23. J.T. Park, M. Li, K. Nakayama, T.L. Mao, B. Davidson, and Z. Zhang et al. Notch3 gene amplification in ovarian cancer Cancer Res 66 2006 6312 6318
24. G.P. Gupta, and J. Massague Cancer metastasis: building a framework Cell 127 2006 679 695
25. T. Bogenrieder, and M. Herlyn Axis of evil: molecular mechanisms of cancer metastasis Oncogene 22 2003 6524 6536
26. A.J. Ridley, M.A. Schwartz, K. Burridge, R.A. Firtel, M.H. Ginsberg, and G. Borisy et al. Cell migration: integrating signals from front to back Science 302 2003 1704 1709
27. H. Yamaguchi, and J. Condeelis Regulation of the actin cytoskeleton in cancer cell migration and invasion Biochim Biophys Acta 1773 2007 642 652
28. E.D. Goley, and M.D. Welch The ARP2/3 complex: an actin nucleator comes of age Nat Rev Mol Cell Biol 7 2006 713 726
29. H. Yamaguchi, M. Lorenz, S. Kempiak, C. Sarmiento, S. Coniglio, and M. Symons et al. Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin J Cell Biol 168 2005 441 452